Jeffcoate William J, Chipchase Susan Y, Ince Paul, Game Fran L
Foot Ulcer Trials Unit, Department of Diabetes and Endocrinology, City Hospital, Nottingham, UK.
Diabetes Care. 2006 Aug;29(8):1784-7. doi: 10.2337/dc06-0306.
The purpose of this study was to compare different outcome measures in the audit of management of diabetic foot ulcers
Data collected prospectively in a consecutive cohort of patients referred to a specialist multidisciplinary foot care clinic between 1 January 2000 and 31 December 2003 were analyzed. A single index ulcer was selected for each patient and classified according to both the Size (Area and Depth), Sepsis, Arteriopathy, and Denervation [S(AD)SAD] and University of Texas (UT) systems. Ulcer-related outcomes (healing, resolution by ipsilateral amputation or by death, and persisting unhealed) were determined at 6 and 12 months and compared with patient-related outcomes (survival, any amputation, and being free from any ulcer) at 12 months.
In 449 patients (63.7% male, mean age 66.7 +/- 13.2 years), 352 (78.4%) ulcers were superficial [S(AD)SAD/UT grade 1] and 134 of these (38.1% of 352) were neither ischemic nor infected. A total of 183 (40.8% of 449) ulcers were clinically infected, and peripheral arterial disease was present in 216 patients (48.1%). Seventeen patients (3.8%) were lost to follow-up and were excluded from analysis. Of the ulcers, 247 (55.0% of 449) and 295 (65.7%) healed without amputation by 6 and 12 months, respectively. Median (range) time to healing was 78 (7-364) days. Of all index ulcers, 5.8 and 8.0% were resolved by amputation, and 6.2 and 10.9% by death by the same time points; 27.8 and 11.6% persisted unhealed. In contrast, patient-related outcomes revealed that of 449 patients only 202 (45.0%) were alive, without amputation, and ulcer free at 12 months. This group had had 272 (1-358) days without any ulcer. A total of 48 (10.7%) patients had undergone some form of amputation, and 75 (16.7%) had died.
These data illustrate the extent to which ulcer-related outcomes may underestimate the true morbidity and mortality associated with diabetic foot disease. It is suggested that when attempts are made to compare the effectiveness of management in different centers, greater emphasis should be placed on patient-related outcome measures.
本研究旨在比较糖尿病足溃疡管理审计中的不同结局指标。
对2000年1月1日至2003年12月31日期间转诊至专科多学科足部护理诊所的连续队列患者进行前瞻性收集的数据进行分析。为每位患者选择一个单一的指标溃疡,并根据大小(面积和深度)、脓毒症、动脉病和去神经支配情况[S(AD)SAD]以及德克萨斯大学(UT)系统进行分类。在6个月和12个月时确定溃疡相关结局(愈合、同侧截肢或死亡导致的溃疡消退以及持续未愈合),并与12个月时的患者相关结局(生存、任何截肢情况以及无任何溃疡)进行比较。
在449例患者中(男性占63.7%,平均年龄66.7±13.2岁),352例(78.4%)溃疡为表浅性[S(AD)SAD/UT 1级],其中134例(占352例的38.1%)既非缺血性也未感染。共有183例(占449例的40.8%)溃疡临床上存在感染,216例患者(48.1%)存在外周动脉疾病。17例患者(3.8%)失访,被排除在分析之外。在这些溃疡中,分别有247例(占449例的55.0%)和295例(65.7%)在6个月和12个月时未截肢而愈合。愈合的中位(范围)时间为78(7 - 364)天。在所有指标溃疡中,在相同时间点分别有5.8%和8.0%通过截肢消退,6.2%和10.9%因死亡消退;27.8%和11.6%持续未愈合。相比之下,患者相关结局显示,在449例患者中,仅202例(45.0%)在12个月时存活、未截肢且无溃疡。该组患者无任何溃疡的时间为272(1 - 358)天。共有48例(10.7%)患者接受了某种形式的截肢,75例(16.7%)患者死亡。
这些数据表明溃疡相关结局可能在多大程度上低估了与糖尿病足病相关的真实发病率和死亡率。建议在尝试比较不同中心的管理效果时,应更加重视患者相关结局指标。